Profil
Jon T.
Holmlund worked as the Medical Director at Aspire IRB LLC.
He was the Vice President-Development at Ionis Pharmaceuticals, Inc. from 1997 to 2004.
From 2004 to 2007, he served as the Chief Medical Officer & Vice President-Development at Ascenta Therapeutics, Inc. He was also a Principal at the National Cancer Institute.
Dr. Holmlund holds a doctorate degree from the State University of New York at Buffalo.
Anciens postes connus de Jon T. Holmlund
| Sociétés | Poste | Fin |
|---|---|---|
| GALERA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/12/2022 |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Directeur Technique/Scientifique/R&D | 01/11/2007 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2004 |
Aspire IRB LLC
Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Operates as an independent review board providing human subject protection oversight in clinical trials for life science companies | Directeur Technique/Scientifique/R&D | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
Formation de Jon T. Holmlund
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
Aspire IRB LLC
Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Operates as an independent review board providing human subject protection oversight in clinical trials for life science companies | Commercial Services |
















